Literature DB >> 17081985

The mechanisms of PML-nuclear body formation.

Tian Huai Shen1, Hui-Kuan Lin, Pier Paolo Scaglioni, Thomas M Yung, Pier Paolo Pandolfi.   

Abstract

PML nuclear bodies (NBs) are nuclear structures that have been implicated in processes such as transcriptional regulation, genome stability, response to viral infection, apoptosis, and tumor suppression. PML has been found to be essential for the formation of the NBs, as these structures do not form in Pml null cells, although PML add back fully rescues their formation. However, the basis for such a structural role of PML is unknown. We demonstrate that PML contains a SUMO binding motif that is independent of its SUMOylation sites and is surprisingly necessary for PML-NB formation. We demonstrate that the PML RING domain is critical for PML SUMOylation and PML-NB formation. We propose a model for PML-NB formation whereby PML SUMOylation and noncovalent binding of PML to SUMOylated PML through the SUMO binding motif constitutes the nucleation event for subsequent recruitment of SUMOylated proteins and/or proteins containing SUMO binding motifs to the PML NBs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081985      PMCID: PMC1978182          DOI: 10.1016/j.molcel.2006.09.013

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  27 in total

Review 1.  The transcriptional role of PML and the nuclear body.

Authors:  S Zhong; P Salomoni; P P Pandolfi
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

Review 2.  PML protein isoforms and the RBCC/TRIM motif.

Authors:  K Jensen; C Shiels; P S Freemont
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

Review 3.  The role of PML in tumor suppression.

Authors:  Paolo Salomoni; Pier Paolo Pandolfi
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

Review 4.  Nuclear and unclear functions of SUMO.

Authors:  Jacob-S Seeler; Anne Dejean
Journal:  Nat Rev Mol Cell Biol       Date:  2003-09       Impact factor: 94.444

5.  Role of SUMO-1-modified PML in nuclear body formation.

Authors:  S Zhong; S Müller; S Ronchetti; P S Freemont; A Dejean; P P Pandolfi
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

6.  Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.

Authors:  A Minty; X Dumont; M Kaghad; D Caput
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

Review 7.  In vivo analysis of the molecular genetics of acute promyelocytic leukemia.

Authors:  P P Pandolfi
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

Review 8.  Body language: the function of PML nuclear bodies in apoptosis regulation.

Authors:  T G Hofmann; H Will
Journal:  Cell Death Differ       Date:  2003-12       Impact factor: 15.828

9.  Cell cycle regulation of PML modification and ND10 composition.

Authors:  R D Everett; P Lomonte; T Sternsdorf; R van Driel; A Orr
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

10.  Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.

Authors:  V Lallemand-Breitenbach; J Zhu; F Puvion; M Koken; N Honoré; A Doubeikovsky; E Duprez; P P Pandolfi; E Puvion; P Freemont; H de Thé
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  223 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.

Authors:  Andrea Rabellino; Brandon Carter; Georgia Konstantinidou; Shwu-Yuan Wu; Alessandro Rimessi; Lauren A Byers; John V Heymach; Luc Girard; Cheng-Ming Chiang; Julie Teruya-Feldstein; Pier Paolo Scaglioni
Journal:  Cancer Res       Date:  2012-03-09       Impact factor: 12.701

3.  Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.

Authors:  Cristy Tower; Lianwu Fu; Rachel Gill; Mark Prichard; Mathieu Lesort; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

Review 4.  The fate of metaphase kinetochores is weighed in the balance of SUMOylation during S phase.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Cell Cycle       Date:  2010-08-09       Impact factor: 4.534

Review 5.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

6.  N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies.

Authors:  Prashant Sharma; Rodolfo Murillas; Huafeng Zhang; Michael R Kuehn
Journal:  J Cell Sci       Date:  2010-03-16       Impact factor: 5.285

7.  Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins.

Authors:  José González-Santamaría; Michela Campagna; María Angel García; Laura Marcos-Villar; Dolores González; Pedro Gallego; Fernando Lopitz-Otsoa; Susana Guerra; Manuel S Rodríguez; Mariano Esteban; Carmen Rivas
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

8.  Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins.

Authors:  Huaiyu Sun; Joel D Leverson; Tony Hunter
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

9.  Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.

Authors:  Behdokht Jan Fada; Elie Kaadi; Subodh Kumar Samrat; Yi Zheng; Haidong Gu
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 10.  SUMO: a multifaceted modifier of chromatin structure and function.

Authors:  Caelin Cubeñas-Potts; Michael J Matunis
Journal:  Dev Cell       Date:  2013-01-14       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.